PG.US Weekly Report · 2026-W31
P&G faced a sharp selloff this week following disappointing Q4 FY2026 earnings and a cautious FY2027 guidance. While revenue growth held steady at 1.5% YoY, net profit fell 14% and diluted EPS collapsed to $1.26 from prior quarter, paired with conservative 2027 growth forecasts that triggered broad liquidation. Though valuation remains at historically depressed levels (P/E in ~7th percentile of 3-year range), capital flows turned negative, and institutional ratings—despite favoring the stock—lag the rapid drawdown.
Price Action
P&G declined from $147.41 at the prior week’s close to $144.49, a loss of 1.98% on the week. Intraweek volatility spanned $144.70 high to $141.46 low, representing a 2.27% range. The sharpest moves occurred around July 29-30 earnings releases, with volume surging to 14.6M shares on July 29 and 9.6M on July 30—both well above the 60-day daily average of ~7.5M shares—marking a classic high-volume selloff. Weekly turnover reached $13.16B with a 0.39% turnover rate, broadly elevated but not extreme. The weekly candle shows a “open-high, close-low” pattern, breaking through support at $148.60 (Monday’s open) and the intermediate zone around $150.46; nearest downside support now sits near $141.
Valuation Positioning
The current P/E of 20.97x places valuation at approximately the 7th percentile of the 3-year range—meaning 88% of the past three years showed cheaper valuations. P/B stands at 6.2x, slightly elevated. Relative to the industry median of 17.26x, P&G carries a premium, though absolute levels now rest in the historical basement. The valuation discount versus history remains pronounced, yet has failed to draw incremental capital inflows post-earnings.
Earnings Delivery
P&G’s Q4 FY2026 (quarter ended June 30, 2026) reported diluted EPS of $1.26, down 22.7% sequentially from Q3’s $1.63 and down 14.8% YoY from Q4 FY2025’s $1.48. Operating revenue of $21.20B grew 1.5% YoY but was flat sequentially versus Q3’s $21.24B. Net income fell 14% YoY to $3.04B and declined 21.1% sequentially from Q3’s $3.86B. Operating profit of $4.14B dropped 21.2% YoY and fell 15.4% QoQ versus Q3’s $4.89B.
Versus forecast EPS consensus of $7.009 for FY2026, the current TTM EPS of $6.89 runs in line; however, Q4’s $1.26 represents a clear miss on historical second-half seasonal strength. FY2027 core EPS guidance of $6.89–$7.11 aligns with the IBES consensus of $7.04 but implies effectively zero growth from FY2026’s TTM of $6.89, with organic sales growth capped at just 1%–3%—a marked deceleration signal.
Capital Flows
As of July 31, institutional and retail flows turned uniformly negative. Large-cap order flow showed net outflows of $941.8M (inflows $473.4M vs. outflows $1,415.2M), mid-cap orders net negative $1,454.4M, and retail net negative $1,300.0M. All three tiers liquidated, consistent with the post-earnings rout. This reversal—from pre-earnings neutral flows to sharply negative—suggests institutional investors moved swiftly to derisk on the cautious FY2027 guidance and bleak profitability trajectory.
Institutional Views
P&G carries 26 analyst ratings: 8 strong buy, 8 buy, 11 hold, 6 underperform, 0 sell, 1 no opinion. The bullish cohort (16/26) dominates, though 6 underperforms merit attention. Ratings were updated as recently as July 30, suggesting rapid post-earnings repricing. The median price target of $160.70 implies 11.2% upside from current levels, but target stickiness is questionable given the quick sell-side downgrades in the aftermath of earnings.
Weekly News
P&G news this week centered on Q4 earnings and FY2027 guidance, with earnings compression and stunted growth the dominant themes:
- Analysts Suggest Buying P&G Stock When Price Falls After Earnings Release
- P&G Targets 1%-3% Organic Sales Growth for FY2027 Amid Persistent Cost Pressure
- Procter & Gamble Issues Cautious Outlook for Fiscal Year 2027
- P&G Reports Organic Sales Flat Despite Rising Costs
- Dow Jones Falls 400 Points; P&G Stock Drops After Q4 Earnings
- P&G Plummets Intraday
- P&G Delivers Over 1% Organic Sales Growth for Fiscal 2026
- P&G’s Earnings Beat Expectations, Yet Stock Falls—Here’s Why
- P&G Q4 Profit Declines; FY2027 Growth Forecast Issued; CEO Jejurikar to Assume Additional Chairman Role; Stock Falls
- Market Focus: P&G Not Fully Out of the Woods, Yet Recovery Signals Emerge
Signal Consistency
P&G presents a telling “cheap valuation vs. capital exit” contradiction. Valuation at the 7th percentile of 3-year history and 16 of 26 analysts bullish should attract bargain hunters; instead, all three capital tiers exited simultaneously on earnings day. This split suggests market participants—especially institutional investors—have front-run the obvious valuation discount with a sharper negative revision to growth and profitability outlooks than backward-looking ratings can accommodate. Ratings likely lag price discovery here. Post-earnings volatility and consensus estimate cuts will be the signals to monitor.